Abstract
In 2008, the US soft tissue repair device market, comprising ventral hernia
repair devices, vaginal slings, inguinal hernia repair devices, pelvic floor
reconstruction (PFR) devices, dural repair devices, rotator cuff reinforcement
grafts, and staple line reinforcement (SLR) devices, was valued at over $1.2
billion.
Growth in this market will be driven by the rising penetration of commercial
meshes, which offer higher efficacy and lower relapse rates than traditional
mesh-free methods of repair and by the adoption of new higher-priced soft
tissue products
|